ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,655, issued on June 3, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).
"RAF kinase inhibitors and methods of use thereof" was invented by Daniel L. Flynn (Waltham, Mass.), Yu Mi Ahn (Waltham, Mass.), Lakshminarayana Vogeti (Waltham, Mass.) and Bertrand Le Bourdonnec (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that are RAF inhibitors and their use in the treatment of disorders such as cancers."
The patent was filed on Dec. 9, 2022, under Application No. 18/078,271.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Se...